Cyanocobalamin/Folinic Acid Injection recalled over sterility concerns
- Recall date
- January 15, 2020
- Source
- U.S. Food & Drug Administration (FDA) — enforcement report
- Official notice title
- Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical recalls Cyanocobalamin/Folinic Acid Injection, CYANOCOBALAMIN : FOLINIC ACID 2000 MCG/ML: 500MCG/ML INJECTABLE, For IV, IM, SC…
- Recall number
- D-0949-2020
- FDA classification
- Class II
- Brand / firm
- Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical
- Sold / distributed
- U.S.A. Nationwide and Puerto Rico, Barbados and Dominican Republic
Why it was recalled
Lack of Assurance of Sterility
Class II means using this product may cause temporary or medically reversible health problems; the chance of serious harm is remote.
What was recalled
Cyanocobalamin/Folinic Acid Injection, CYANOCOBALAMIN : FOLINIC ACID 2000 MCG/ML: 500MCG/ML INJECTABLE, For IV, IM, SC Use, 30 mL Multi-dose Vial, Rx only, Axia Pharmaceutical 1990 Westwood Blvd. Ste 135, Los Angeles, CA 90025; NDC 71283-0333-3
Get recall alerts
Free email alert whenever Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical has a new recall — straight from official government data. Unsubscribe anytime.
More recalls from: Fusion IV Pharmaceuticals, Inc. dba Axia Pharmaceutical